GB2398495B - A drug delivery preparation comprising at least one anti-tumour drug and a topical carrier for the drug - Google Patents
A drug delivery preparation comprising at least one anti-tumour drug and a topical carrier for the drugInfo
- Publication number
- GB2398495B GB2398495B GB0301562A GB0301562A GB2398495B GB 2398495 B GB2398495 B GB 2398495B GB 0301562 A GB0301562 A GB 0301562A GB 0301562 A GB0301562 A GB 0301562A GB 2398495 B GB2398495 B GB 2398495B
- Authority
- GB
- United Kingdom
- Prior art keywords
- drug
- tumour
- topical carrier
- delivery preparation
- drug delivery
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 229940041181 antineoplastic drug Drugs 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 238000012377 drug delivery Methods 0.000 title 1
- 230000000699 topical effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0301562A GB2398495B (en) | 2003-01-23 | 2003-01-23 | A drug delivery preparation comprising at least one anti-tumour drug and a topical carrier for the drug |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0301562A GB2398495B (en) | 2003-01-23 | 2003-01-23 | A drug delivery preparation comprising at least one anti-tumour drug and a topical carrier for the drug |
Publications (3)
Publication Number | Publication Date |
---|---|
GB0301562D0 GB0301562D0 (en) | 2003-02-26 |
GB2398495A GB2398495A (en) | 2004-08-25 |
GB2398495B true GB2398495B (en) | 2007-08-22 |
Family
ID=9951672
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0301562A Expired - Lifetime GB2398495B (en) | 2003-01-23 | 2003-01-23 | A drug delivery preparation comprising at least one anti-tumour drug and a topical carrier for the drug |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2398495B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2015120720A (en) * | 2005-02-02 | 2015-07-02 | ネクスジェニクス・ファーマシューティカルズ,リミテッド・ライアビリティ・カンパニー | Local treatment of neurofibromas |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1854465A1 (en) | 2006-05-12 | 2007-11-14 | Alexander Tobias Teichmann | Use of 4,17 beta-dihydroxyandrost-4-ene-3-one for treating cancers |
GB0623768D0 (en) * | 2006-11-28 | 2007-01-10 | Chopra Sunil | A bleomycin preparation for use against skin tumours |
GB2595502B (en) * | 2020-05-28 | 2023-01-11 | Chopra Sunil | Compounds, compositions and methods for the treatment or prevention of hair loss |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4156719A (en) * | 1977-02-28 | 1979-05-29 | Yamanouchi Pharmaceutical Co., Ltd. | Compositions for rectal use |
EP0219922A2 (en) * | 1985-10-15 | 1987-04-29 | Vestar, Inc. | Anthracycline antineoplastic agents encapsulated in phospholipid micellular particles |
JPH0374334A (en) * | 1989-08-11 | 1991-03-28 | Nippon Oil & Fats Co Ltd | Reinforcing of carcinostatic property of bleomycin |
EP0526666A1 (en) * | 1991-08-05 | 1993-02-10 | Maria Rosa Gasco | Solid lipid microspheres having a narrow size distribution and method for producing them |
GB2315216A (en) * | 1993-10-05 | 1998-01-28 | Ciba Geigy Ag | Microemulsion preconcentrates comprising FK 506 |
GB2327610A (en) * | 1994-11-04 | 1999-02-03 | Novartis Ag | Stabilisation of Macrolide Compositions |
WO2000024377A1 (en) * | 1998-10-23 | 2000-05-04 | Idea Innovative Dermale Applikationen Gmbh | Method for developing, testing and using associates of macromolecules and complex aggregates for improved payload and controllable de/association rates |
WO2001001962A1 (en) * | 1999-07-05 | 2001-01-11 | Idea Ag. | A method for the improvement of transport across adaptable semi-permeable barriers |
-
2003
- 2003-01-23 GB GB0301562A patent/GB2398495B/en not_active Expired - Lifetime
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4156719A (en) * | 1977-02-28 | 1979-05-29 | Yamanouchi Pharmaceutical Co., Ltd. | Compositions for rectal use |
EP0219922A2 (en) * | 1985-10-15 | 1987-04-29 | Vestar, Inc. | Anthracycline antineoplastic agents encapsulated in phospholipid micellular particles |
JPH0374334A (en) * | 1989-08-11 | 1991-03-28 | Nippon Oil & Fats Co Ltd | Reinforcing of carcinostatic property of bleomycin |
EP0526666A1 (en) * | 1991-08-05 | 1993-02-10 | Maria Rosa Gasco | Solid lipid microspheres having a narrow size distribution and method for producing them |
GB2315216A (en) * | 1993-10-05 | 1998-01-28 | Ciba Geigy Ag | Microemulsion preconcentrates comprising FK 506 |
GB2327610A (en) * | 1994-11-04 | 1999-02-03 | Novartis Ag | Stabilisation of Macrolide Compositions |
WO2000024377A1 (en) * | 1998-10-23 | 2000-05-04 | Idea Innovative Dermale Applikationen Gmbh | Method for developing, testing and using associates of macromolecules and complex aggregates for improved payload and controllable de/association rates |
WO2001001962A1 (en) * | 1999-07-05 | 2001-01-11 | Idea Ag. | A method for the improvement of transport across adaptable semi-permeable barriers |
Non-Patent Citations (1)
Title |
---|
WPI Acc. No. 1991-136900 [25] & JP 3074334 A (NIPPON OILS & FATS) * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2015120720A (en) * | 2005-02-02 | 2015-07-02 | ネクスジェニクス・ファーマシューティカルズ,リミテッド・ライアビリティ・カンパニー | Local treatment of neurofibromas |
Also Published As
Publication number | Publication date |
---|---|
GB0301562D0 (en) | 2003-02-26 |
GB2398495A (en) | 2004-08-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL165480A0 (en) | Topical drug delivery using phosphatidylcholine | |
IL174690A0 (en) | Enhanced drug delivery | |
GB2404867B (en) | Delivery devices | |
GB2405350B (en) | Delivery devices | |
EP1379291A4 (en) | Integrated medication delivery system | |
GB2391480B (en) | Drug delivery system | |
SI1631255T1 (en) | Drug delivery system | |
GB0400024D0 (en) | Delivery devices | |
GB2385273B (en) | Drug delivery device | |
EP1450876A4 (en) | Integrated transdermal drug delivery system | |
EG24425A (en) | Drug delivery assembly | |
GB2398495B (en) | A drug delivery preparation comprising at least one anti-tumour drug and a topical carrier for the drug | |
ZA200510411B (en) | Delivery system for topical medications | |
GB0215593D0 (en) | New anticancer drugs | |
IL156837A0 (en) | Topical drug delivery system | |
GB0209411D0 (en) | Drug delivery | |
GB0217478D0 (en) | Multiple-therapy drug delivery | |
GB0311084D0 (en) | Drug delivery | |
GB0329141D0 (en) | Drug delivery | |
GB0118366D0 (en) | Multiple-therapy drug delivery | |
GB0102667D0 (en) | Drug delivery | |
IL151579A0 (en) | Drug delivery device | |
PT1393763T (en) | Drug delivery device | |
GB0313748D0 (en) | Drug delivery compounds | |
GB0102586D0 (en) | Drug delivery device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PE20 | Patent expired after termination of 20 years |
Expiry date: 20230122 |